These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7975834

  • 1. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
    Ma J, Bulger PA, Davis DR, Perilli-Palmer B, Bedore DA, Kensil CR, Young EM, Hung CH, Seals JR, Pavia CS.
    Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
    [Abstract] [Full Text] [Related]

  • 2. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
    Ma J, Bulger PA, Dante S, Davis DR, Perilli-Palmer B, Coughlin RT.
    J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
    [Abstract] [Full Text] [Related]

  • 3. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE, Wallich R, Kramer MD, Gern L, Anderson JF, Museteanu C, Simon MM.
    Vaccine; 1993 Apr; 11(10):1049-54. PubMed ID: 8212826
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS, LeFebvre RB.
    Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
    [Abstract] [Full Text] [Related]

  • 6. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.
    Munson EL, Du Chateau BK, Jobe DA, Lovrich SD, Callister SM, Schell RF.
    Infect Immun; 2000 Oct; 68(10):5496-501. PubMed ID: 10992445
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.
    Moskophidis M, Luther B.
    Zentralbl Bakteriol; 1993 Jun; 279(2):201-13. PubMed ID: 8219491
    [Abstract] [Full Text] [Related]

  • 8. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
    Ma Y, Weis JJ.
    Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.
    J Immunol; 2001 Jun 15; 166(12):7398-403. PubMed ID: 11390491
    [Abstract] [Full Text] [Related]

  • 10. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
    Coughlin RT, Fish D, Mather TN, Ma J, Pavia C, Bulger P.
    J Infect Dis; 1995 Apr 15; 171(4):1049-52. PubMed ID: 7706788
    [Abstract] [Full Text] [Related]

  • 11. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Apr 15; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 12. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
    Roehrig JT, Piesman J, Hunt AR, Keen MG, Happ CM, Johnson BJ.
    J Immunol; 1992 Dec 01; 149(11):3648-53. PubMed ID: 1431134
    [Abstract] [Full Text] [Related]

  • 13. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
    Fikrig E, Tao H, Kantor FS, Barthold SW, Flavell RA.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):4092-6. PubMed ID: 7683420
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.
    Ma J, Gingrich-Baker C, Franchi PM, Bulger P, Coughlin RT.
    Infect Immun; 1995 Jun 01; 63(6):2221-7. PubMed ID: 7539408
    [Abstract] [Full Text] [Related]

  • 15. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
    Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS.
    Infect Immun; 1998 Nov 01; 66(11):5379-87. PubMed ID: 9784547
    [Abstract] [Full Text] [Related]

  • 16. Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.
    Solé M, Bantar C, Indest K, Gu Y, Ramamoorthy R, Coughlin R, Philipp MT.
    Infect Immun; 1998 Jun 01; 66(6):2540-6. PubMed ID: 9596714
    [Abstract] [Full Text] [Related]

  • 17. Consensus sequence on the genes encoding the major outer surface proteins (OspA and OspB) of Borrelia garinii isolate.
    Wang J, Masuzawa T, Komikado T, Yanagihara Y.
    Microbiol Immunol; 1997 Jun 01; 41(2):83-91. PubMed ID: 9087950
    [Abstract] [Full Text] [Related]

  • 18. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, Patrican LA, Mohammed H, Summers BA.
    Infect Immun; 1995 Sep 01; 63(9):3543-9. PubMed ID: 7642289
    [Abstract] [Full Text] [Related]

  • 19. OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant.
    Erdile LF, Guy B.
    Vaccine; 1997 Jun 01; 15(9):988-96. PubMed ID: 9261945
    [Abstract] [Full Text] [Related]

  • 20. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
    Kalish RA, Leong JM, Steere AC.
    Infect Immun; 1993 Jul 01; 61(7):2774-9. PubMed ID: 7685738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.